Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
AVBP ArriVent BioPharma
- 19.500
- -1.060-5.16%
Close Mar 18 16:00 ET
- 19.500
- 0.0000.00%
Post 16:05 ET
663.32MMarket Cap-8.17P/E (TTM)
20.430High19.490Low117.57KVolume20.430Open20.560Pre Close2.33MTurnover0.74%Turnover RatioLossP/E (Static)34.02MShares36.37052wk High2.57P/B308.86MFloat Cap14.35052wk Low--Dividend TTM15.84MShs Float36.370Historical High--Div YieldTTM4.57%Amplitude14.350Historical Low19.788Avg Price1Lot Size
About ArriVent BioPharma Company
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Company Profile
SymbolAVBP
Company NameArriVent BioPharma
Listing DateJan 26, 2024
Issue Price18.00
Founded2021
CEODr. Zhengbin Yao, PhD
MarketNASDAQ
Employees52
Fiscal Year Ends12-31
Address18 Campus Boulevard,Suite 100
CityNewtown Square
ProvincePennsylvania
CountryUnited States of America
Zip Code19073
Phone1-628-277-4836
Websitehttp://www.arrivent.com
Company Executives
- Name
- Position
- Salary
- Dr. Zhengbin Yao, PhD
- Chairman of Board and Chief Executive Officer
- 1.19M
- Winston Kung, M.B.A.
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- --
- Robin LaChapelle, M.D.
- Chief Operating Officer
- 960.99K
- Dr. Stuart Lutzker, M.D.,PhD
- Director and President, Research and Development
- 828.75K
- Dr. Carl L. Gordon, C.F.A.,PhD
- Director
- --
- Dr. James I. Healy, M.D.,PhD
- Independent Director
- --
- Kristine Peterson
- Independent Director
- --
- Christian W. Nolet, C.P.A.
- Independent Director
- 79.28K
- Dr. John A. Hohneker, M.D.
- Independent Director
- --
- James Paul Kastenmayer, J.D.,PhD
- General Counsel and Secretary
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.